Cite
HARVARD Citation
Tempestilli, M. et al. (2018). Development and validation of an HPLC‐UV method for quantification of elvitegravir and two other new antiretrovirals, dolutegravir and rilpivirine, in the plasma of HIV‐positive patients. Biomedical chromatography. p. n/a. [Online].